Omega Therapeutics (OMGA) Insider Trading & Ownership $0.12 -0.03 (-21.83%) Closing price 02/24/2025Extended Trading$0.12 0.00 (0.00%) As of 02/24/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Omega Therapeutics (NASDAQ:OMGA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.50%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$19.21MNumber OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$400K Get OMGA Insider Trade Alerts Want to know when executives and insiders are buying or selling Omega Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address OMGA Insider Buying and Selling by Quarter Omega Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/1/2023Richard A YoungDirectorSell5,000$8.00$40,000.00 4/6/2023Richard A YoungDirectorSell5,000$8.00$40,000.00 3/17/2023Richard A YoungDirectorSell10,000$8.00$80,000.00 2/27/2023Flagship Pioneering Inc.Major ShareholderBuy3,323,310$5.78$19,208,731.80 1/10/2023Richard A YoungDirectorSell20,000$8.00$160,000.00 9/14/2022Richard A YoungDirectorSell10,000$8.00$80,000.00 (Data available from 1/1/2013 forward) OMGA Insider Trading Activity - Frequently Asked Questions Who is on Omega Therapeutics' Insider Roster? The list of insiders at Omega Therapeutics includes Flagship Pioneering Inc., and Richard A Young. Learn more on insiders at OMGA. What percentage of Omega Therapeutics stock is owned by insiders? 8.50% of Omega Therapeutics stock is owned by insiders. Learn more on OMGA's insider holdings. Omega Therapeutics Key ExecutivesMr. Mahesh Karande (Age 50)President, CEO & Board Director Compensation: $910.39kMr. Joshua Reed M.B.A. (Age 51)Chief Financial Officer Compensation: $659.39kDr. Yan Moore M.D. (Age 57)Chief Medical Officer Compensation: $738.34kDr. Thomas McCauley Ph.D. (Age 55)Chief Scientific Officer Compensation: $588.5kMs. Ling Zeng Esq. (Age 55)J.D., Chief Legal & Administrative Officer and Secretary Compensation: $519.36kMr. Anthony MullinChief People OfficerMs. Barbara Y. Chan (Age 60)Senior Vice President of Finance Mr. Charles O'Donnell Ph.D.VP and Head of Computational Genomics & Data Sciences More Insider Trading Tools from MarketBeat Related Companies Cadrenal Therapeutics Insider Buying Generation Bio Insider Buying FibroGen Insider Buying Tempest Therapeutics Insider Buying Passage Bio Insider Buying Cara Therapeutics Insider Buying CalciMedica Insider Buying Cyclo Therapeutics Insider Buying Relmada Therapeutics Insider Buying BioAtla Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Tech Stocks With High and Rising Institutional Interest3 Summer Stocks With Insider Buying and Analyst Support3 Tightly-Held Growth Stocks Set Up for Short SqueezesTankers, Takedowns & Air Taxis: Insiders Are Buying These 3 Names3 Tech Stocks Insiders Are Buying: Speculative Plays for June This page (NASDAQ:OMGA) was last updated on 6/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omega Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Omega Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.